Haleon Expects Solid Margin Growth Despite Weaker Cold Season
ByAinvest
Thursday, Jan 22, 2026 9:40 am ET1min read
HLN--
Haleon PLC is expected to report solid sales growth of 3.2% for FY25, despite a weaker cold and flu season in key markets. The company's profit margin is forecast to improve by 50 basis points to 22.8%. Oral health remains the star performer, while therapeutic skin health is expected to soften. For 2026, Haleon is likely to reaffirm its medium-term targets of 4-6% sales growth and high single-digit profit growth.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet